Concepedia

Jayanshu Jain

JJ

Statistics

Publications

8

Citations

399

H-Index

8

Active since

2006

Affiliations

Dana-Farber Cancer Institute(Current)

Fred Hutch Cancer Center

Emory University

Tulane University

University of Washington

Jayanshu Jain is an author at Dana-Farber Cancer Institute specializing in oncology, medicine, and immunotherapy.

Publications per year

2006–2022

8

Publications

8

Impact of performance status on treatment outcomes: A real‐world study of advanced urothelial cancer treated with immune checkpoint inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · Cancer · 2019 · 90 citations · Full text

, , +16

Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study

Vadim S. Koshkin, Nicholas Henderson, Marihella James et al. · Cancer · 2021 · 85 citations · Full text

, , +12

A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors

Ali Raza Khaki, Ang Li, Leonidas Nikolaos Diamantopoulos et al. · European Urology Oncology · 2021 · 62 citations · Full text

, , +16

Histological Subtypes and Response to PD-1/PD-L1 Blockade in Advanced Urothelial Cancer: A Retrospective Study

Natalie Miller, Ali Raza Khaki, Leonidas Nikolaos Diamantopoulos et al. · The Journal of Urology · 2020 · 61 citations · Full text

, , +17

Can Dose Reduction to One Parotid Gland Prevent Xerostomia? — A Feasibility Study for Locally Advanced Head and Neck Cancer Patients Treated with Intensity-modulated Radiotherapy

Aman Anand, Jayanshu Jain, P S Negi et al. · Clinical Oncology · 2006 · 40 citations

, , +15

1–5 of 8